Bank Of New York Mellon Corp Neogenomics Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $6.95 Million - $13 Million	1,077,782 New	1,077,782 $9.96 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $396,222 - $650,793	50,410 Added 4.79%	1,103,581 $9.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $932,188 - $1.84 Million	-132,038 Reduced 11.14%	1,053,171 $8.58 Million
Q1 2022 May 11, 2022	SELL	$12.15 - $35.28 $2.48 Million - $7.21 Million	-204,280 Reduced 14.7%	1,185,209 $14.4 Million
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $876,496 - $1.39 Million	-28,747 Reduced 2.03%	1,389,489 $47.4 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $1.15 Million - $1.45 Million	27,579 Added 1.98%	1,418,236 $68.4 Million
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $641,399 - $905,350	-17,515 Reduced 1.24%	1,390,657 $62.8 Million
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $77,592 - $111,795	-1,867 Reduced 0.13%	1,408,172 $67.9 Million
Q4 2020 Feb 09, 2021	BUY	$36.08 - $56.47 $78,762 - $123,274	2,183 Added 0.16%	1,410,039 $75.9 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $403,310 - $490,860	-12,126 Reduced 0.85%	1,407,856 $51.9 Million
Q2 2020 Aug 12, 2020	SELL	$24.21 - $31.02 $982,393 - $1.26 Million	-40,578 Reduced 2.78%	1,419,982 $44 Million
Q1 2020 May 06, 2020	SELL	$20.5 - $34.53 $1.44 Million - $2.43 Million	-70,365 Reduced 4.6%	1,460,560 $40.3 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $781,170 - $1.23 Million	41,201 Added 2.77%	1,530,925 $44.8 Million
Q3 2019 Nov 07, 2019	SELL	$19.12 - $26.24 $913,190 - $1.25 Million	-47,761 Reduced 3.11%	1,489,724 $28.5 Million
Q2 2019 Aug 12, 2019	SELL	$19.57 - $24.1 $5.73 Million - $7.06 Million	-292,755 Reduced 16.0%	1,537,485 $33.7 Million
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $12.7 Million - $21.4 Million	1,047,450 Added 133.81%	1,830,240 $37.4 Million
Q4 2018 Feb 11, 2019	SELL	$11.24 - $18.5 $1.12 Million - $1.84 Million	-99,454 Reduced 11.27%	782,790 $9.87 Million
Q3 2018 Nov 09, 2018	BUY	$12.5 - $15.38 $2.28 Million - $2.8 Million	182,172 Added 26.02%	882,244 $0
Q2 2018 Aug 06, 2018	SELL	$7.99 - $14.05 $27,485 - $48,332	-3,440 Reduced 0.49%	700,072 $9.18 Million
Q1 2018 May 15, 2018	SELL	$7.23 - $8.76 $829,165 - $1 Million	-114,684 Reduced 14.02%	703,512 $5.74 Million
Q4 2017 Feb 09, 2018	BUY	$8.02 - $11.18 $6.56 Million - $9.15 Million	818,196	818,196 $7.25 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$322 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$230 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$113 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$108 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$107 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account